Related Reading

FDA Shortens Time to Booster After Moderna Vaccine to 5 Months

FRIDAY, Jan. 7, 2022 (HealthDay News) -- Citing the rapid spread of the Omicron variant and the need for protection against it, U.S. federal health officials are shortening the recommended time between the second dose of the Moderna vaccine and a booster shot from six months down to five.

"The country is in the middle of a wave of the highly contagious Omicron variant, which spreads more rapidly than the original SARS-CoV-2 virus and other variants that have emerged," Dr. Peter Marks, director of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research, said in a statement.

"Vaccination is our best defense against COVID-19, including the circulating variants, and shortening the length of time between completion of a primary series and a booster dose may help reduce waning immunity," he said. "Today's action also brings consistency in the timing for administration of a booster dose among the available mRNA vaccines. We encourage everyone to get vaccinated -- it's never too late to get your COVID-19 vaccine or booster."

The new recommendation applies to everyone aged 18 and older. The FDA notes that side effects from the booster shot are typically mild -- some discomfort at the site of injection and transient fatigue, headache or muscle aches.

A similar time window for boosters is already in place for people who received the Pfizer/BioNTech vaccine.

More boosters could be in Americans' future, Moderna CEO Stephane Bancel noted on Thursday.

While the boosters that millions of Americans have recently received should hold strong through this winter's Omicron surge, Bancel said the efficacy of boosters will probably decline over the course of several months, similar to what happened with the first two doses.

"I will be surprised when we get that data in the coming weeks that it's holding nicely over time -- I would expect that it's not going to hold great," Bancel said of the booster shots during an interview with Goldman Sachs during its health care CEO conference, CNBC reported.

More information:

Find out more about COVID-19 vaccine booster shots at the U.S. Centers for Disease Control and Prevention.

SOURCE: U.S. Food and Drug Administration, news release; CNBC

Copyright ©2022 HealthDay. All rights reserved.